The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 27, 2026 | Miller Andrew Craig | Director | Grant(A) | 26K | — | $0 |
| May 14, 2026 | Etkin Amit | PRESIDENT AND CEO, Director | Gift(G) | 400K | — | $0 |
| May 12, 2026 | Dreyfus Andrew | Director | Grant(A) | 11K | — | $0 |
| May 12, 2026 | Sanchez Ramiro | Director | Grant(A) | 11K | — | $0 |
| May 12, 2026 | Cox Christopher Nixon | Director | Grant(A) | 11K | — | $0 |
| May 12, 2026 | York Gwill | Director | Grant(A) | 11K | — | $0 |
| May 12, 2026 | Manji Husseini | Director | Grant(A) | 11K | — | $0 |
| Mar 1, 2026 | Etkin Amit | PRESIDENT AND CEO, Director | Tax withholding(F) | 6K | $19.69 | $123K |
| Mar 1, 2026 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Tax withholding(F) | 3K | $19.69 | $55K |
| Feb 11, 2026 | Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | Grant(A) | 131K | — | $0 |
| Feb 11, 2026 | Etkin Amit | PRESIDENT AND CEO, Director | Grant(A) | 306K | — | $0 |
| Feb 11, 2026 | Savitz Adam | CHIEF MEDICAL OFFICER | Grant(A) | 124K | — | $0 |
| Feb 11, 2026 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Grant(A) | 200K | — | $0 |
| Jan 2, 2026 | Sanchez Ramiro | Director | Grant(A) | 4K | $11.82 | $45K |
| Jan 2, 2026 | Cox Christopher Nixon | Director | Grant(A) | 7K | $11.82 | $85K |
| Jan 2, 2026 | York Gwill | Director | Grant(A) | 5K | $11.82 | $62K |
| Jan 2, 2026 | Manji Husseini | Director | Grant(A) | 4K | $11.82 | $50K |
| Aug 12, 2025 | Sanchez Ramiro | Director | Grant(A) | 4K | $2.21 | $9K |
| Aug 12, 2025 | Sanchez Ramiro | Director | Grant(A) | 31K | — | $0 |
| Jul 3, 2025 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Disposed to issuer(D) | 45K | — | — |
| Jul 3, 2025 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Grant(A) | 45K | — | — |
| Jul 3, 2025 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Grant(A) | 34K | — | — |
| Jul 3, 2025 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Disposed to issuer(D) | 34K | — | — |
| Jul 3, 2025 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Grant(A) | 202K | — | — |
| Jul 3, 2025 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Disposed to issuer(D) | 202K | — | — |
| Jul 3, 2025 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Grant(A) | 90K | — | — |
| Jul 3, 2025 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Disposed to issuer(D) | 90K | — | — |
| Jul 3, 2025 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Grant(A) | 135K | — | — |
| Jul 3, 2025 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Disposed to issuer(D) | 135K | — | — |
| Jul 3, 2025 | Etkin Amit | PRESIDENT AND CEO, Director | Disposed to issuer(D) | 215K | — | — |
| Jul 3, 2025 | Etkin Amit | PRESIDENT AND CEO, Director | Grant(A) | 215K | — | — |
| Jul 3, 2025 | Etkin Amit | PRESIDENT AND CEO, Director | Disposed to issuer(D) | 223K | — | — |
| Jul 3, 2025 | Etkin Amit | PRESIDENT AND CEO, Director | Grant(A) | 223K | — | — |
| Jul 3, 2025 | Etkin Amit | PRESIDENT AND CEO, Director | Disposed to issuer(D) | 247K | — | — |
| Jul 3, 2025 | Etkin Amit | PRESIDENT AND CEO, Director | Grant(A) | 247K | — | — |
| Jul 3, 2025 | Etkin Amit | PRESIDENT AND CEO, Director | Disposed to issuer(D) | 35K | — | — |
| Jul 3, 2025 | Etkin Amit | PRESIDENT AND CEO, Director | Grant(A) | 35K | — | — |
| Jul 3, 2025 | Savitz Adam | CHIEF MEDICAL OFFICER | Disposed to issuer(D) | 76K | — | — |
| Jul 3, 2025 | Savitz Adam | CHIEF MEDICAL OFFICER | Grant(A) | 76K | — | — |
| Jul 3, 2025 | Savitz Adam | CHIEF MEDICAL OFFICER | Disposed to issuer(D) | 73K | — | — |
| Jul 3, 2025 | Savitz Adam | CHIEF MEDICAL OFFICER | Grant(A) | 73K | — | — |
| Jul 3, 2025 | Savitz Adam | CHIEF MEDICAL OFFICER | Disposed to issuer(D) | 124K | — | — |
| Jul 3, 2025 | Savitz Adam | CHIEF MEDICAL OFFICER | Grant(A) | 124K | — | — |
| Jul 3, 2025 | Savitz Adam | CHIEF MEDICAL OFFICER | Disposed to issuer(D) | 33K | — | — |
| Jul 3, 2025 | Savitz Adam | CHIEF MEDICAL OFFICER | Grant(A) | 33K | — | — |
| Jul 3, 2025 | Savitz Adam | CHIEF MEDICAL OFFICER | Disposed to issuer(D) | 22K | — | — |
| Jul 3, 2025 | Savitz Adam | CHIEF MEDICAL OFFICER | Grant(A) | 22K | — | — |
| Jul 3, 2025 | Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | Disposed to issuer(D) | 8K | — | — |
| Jul 3, 2025 | Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | Grant(A) | 188K | — | — |
| Jul 3, 2025 | Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | Disposed to issuer(D) | 188K | — | — |
| Jul 3, 2025 | Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | Grant(A) | 125K | — | — |
| Jul 3, 2025 | Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | Grant(A) | 8K | — | — |
| Jul 3, 2025 | Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | Disposed to issuer(D) | 125K | — | — |
| May 13, 2025 | York Gwill | Director | Grant(A) | 15K | — | $0 |
| May 13, 2025 | Dreyfus Andrew | Director | Grant(A) | 15K | — | $0 |
| May 13, 2025 | Cox Christopher Nixon | Director | Grant(A) | 15K | — | $0 |
| May 13, 2025 | Manji Husseini | Director | Grant(A) | 15K | — | $0 |
| Feb 5, 2025 | Etkin Amit | PRESIDENT AND CEO, Director | Grant(A) | 215K | — | $0 |
| Feb 5, 2025 | Savitz Adam | CHIEF MEDICAL OFFICER | Grant(A) | 76K | — | $0 |
| Feb 5, 2025 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | Grant(A) | 135K | — | $0 |
| Feb 5, 2025 | Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | Grant(A) | 125K | — | $0 |
| Jan 2, 2025 | Cox Christopher Nixon | Director | Grant(A) | 25K | $3.17 | $80K |
| Jan 2, 2025 | Manji Husseini | Director | Grant(A) | 14K | $3.17 | $45K |
| Jan 2, 2025 | York Gwill | Director | Grant(A) | 20K | $3.17 | $62K |
| Jul 10, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy(P) | 3K | $13.22 | $39K |
| Jul 9, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy(P) | 11K | $12.53 | $134K |
| Jul 9, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy(P) | 1K | $13.15 | $18K |
| May 20, 2024 | Hanley Jr. Michael Conick | Chief Operating Officer | Grant(A) | 188K | — | $0 |
| Mar 28, 2024 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Buy(P) | 2K | $15.80 | $25K |
| Mar 28, 2024 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Buy(P) | 5K | $16.56 | $75K |
| Mar 8, 2024 | Radhakrishnan Maha | Director | Grant(A) | 31K | — | $0 |
| Mar 8, 2024 | Radhakrishnan Maha | Director | Grant(A) | 2K | $10.21 | $16K |
| Mar 1, 2024 | Etkin Amit | PRESIDENT AND CEO, Director | Grant(A) | 35K | — | $0 |
| Mar 1, 2024 | Etkin Amit | PRESIDENT AND CEO, Director | Grant(A) | 223K | — | $0 |
| Mar 1, 2024 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Grant(A) | 19K | — | $0 |
| Mar 1, 2024 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Grant(A) | 90K | — | $0 |
| Mar 1, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Grant(A) | 73K | — | $0 |
| Feb 6, 2024 | Alpha Wave Global, LP | 10% Owner | Buy(P) | 600K | $16.00 | $9.6M |
| Feb 6, 2024 | Alpha Wave Global, LP | 10% Owner | Conversion(C) | 1.1M | — | — |
| Feb 6, 2024 | Alpha Wave Global, LP | 10% Owner | Conversion(C) | 2.0M | — | — |
| Feb 6, 2024 | Alpha Wave Global, LP | 10% Owner | Conversion(C) | 2.0M | — | $0 |
| Feb 6, 2024 | Alpha Wave Global, LP | 10% Owner | Conversion(C) | 1.1M | — | $0 |
| Feb 6, 2024 | Apeiron Investment Group Ltd. | Insider | Conversion(C) | 675K | — | — |
| Feb 6, 2024 | Apeiron Investment Group Ltd. | Insider | Conversion(C) | 252K | — | — |
| Feb 6, 2024 | Apeiron Investment Group Ltd. | Insider | Conversion(C) | 406K | — | — |
| Feb 6, 2024 | Apeiron Investment Group Ltd. | Insider | Conversion(C) | 417K | — | — |
| Feb 6, 2024 | Apeiron Investment Group Ltd. | Insider | Conversion(C) | 445K | — | — |
| Feb 6, 2024 | Apeiron Investment Group Ltd. | Insider | Conversion(C) | 1.1M | — | — |
| Feb 6, 2024 | Chen Po Yu (Jeff) | Director | Conversion(C) | 8K | — | — |
| Feb 6, 2024 | Chen Po Yu (Jeff) | Director | Conversion(C) | 39K | — | — |
| Feb 6, 2024 | Chen Po Yu (Jeff) | Director | Conversion(C) | 83K | — | $0 |
| Feb 6, 2024 | Chen Po Yu (Jeff) | Director | Conversion(C) | 19K | — | $0 |
| Feb 6, 2024 | Etkin Amit | PRESIDENT AND CEO, Director | Buy(P) | 3K | $16.00 | $50K |
| Feb 6, 2024 | Etkin Amit | PRESIDENT AND CEO, Director | Conversion(C) | 12K | — | — |
| Feb 6, 2024 | Etkin Amit | PRESIDENT AND CEO, Director | Conversion(C) | 25K | — | $0 |
| Feb 6, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy(P) | 17K | $16.00 | $272K |
| Feb 6, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Conversion(C) | 8K | — | — |
| Feb 6, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Conversion(C) | 17K | — | $0 |
| Feb 6, 2024 | Cox Christopher Nixon | Director | Conversion(C) | 127K | — | — |
| Feb 6, 2024 | Cox Christopher Nixon | Director | Conversion(C) | 589K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).